The 2014International Workshop on Alport Syndrome.
Identifieur interne : 003403 ( PubMed/Corpus ); précédent : 003402; suivant : 003404The 2014International Workshop on Alport Syndrome.
Auteurs : Jeffrey H. Miner ; Colin Baigent ; Frances Flinter ; Oliver Gross ; Parminder Judge ; Clifford E. Kashtan ; Sharon Lagas ; Judith Savige ; Dave Blatt ; Jie Ding ; Daniel P. Gale ; Julian P. Midgley ; Sue Povey ; Marco Prunotto ; Daniel Renault ; Jules Skelding ; A Neil Turner ; Susie GearSource :
- Kidney international [ 1523-1755 ] ; 2014.
English descriptors
- KwdEn :
- Animals, Autoantigens (genetics), Autoantigens (metabolism), Clinical Trials as Topic, Collagen Type IV (genetics), Collagen Type IV (metabolism), Genetic Testing, Glomerular Basement Membrane (metabolism), Humans, Nephritis, Hereditary (diagnosis), Nephritis, Hereditary (drug therapy), Nephritis, Hereditary (genetics), Patient Selection, Podocytes, Registries.
- MESH :
- chemical , genetics : Autoantigens, Collagen Type IV.
- chemical , metabolism : Autoantigens, Collagen Type IV.
- diagnosis : Nephritis, Hereditary.
- drug therapy : Nephritis, Hereditary.
- genetics : Nephritis, Hereditary.
- metabolism : Glomerular Basement Membrane.
- Animals, Clinical Trials as Topic, Genetic Testing, Humans, Patient Selection, Podocytes, Registries.
Abstract
Alport syndrome, historically referred to as hereditary glomerulonephritis with sensorineural deafness and anterior lenticonus, is a genetic disease of collagen α3α4α5(IV) resulting in renal failure. The collagen α3α4α5(IV) heterotrimer forms a network that is a major component of the kidney glomerular basement membrane (GBM) and basement membranes in the cochlea and eye. Alport syndrome, estimated to affect 1 in 5000-10,000 individuals, is caused by mutations in any one of the three genes that encode the α chain components of the collagen α3α4α5(IV) heterotrimer: COL4A3, COL4A4, and COL4A5. Although angiotensin-converting enzyme inhibition is effective in Alport syndrome patients for slowing progression to end-stage renal disease, it is neither a cure nor an adequate long-term protector. The 2014 International Workshop on Alport Syndrome, held in Oxford, UK, from January 3-5, was organized by individuals and families living with Alport syndrome, in concert with international experts in the clinical, genetic, and basic science aspects of the disease. Stakeholders from diverse communities-patient families, physicians, geneticists, researchers, Pharma, and funding organizations-were brought together so that they could meet and learn from each other and establish strategies and collaborations for the future, with the overall aim of discovering much needed new treatments to prolong kidney function.
DOI: 10.1038/ki.2014.229
PubMed: 24988067
Links to Exploration step
pubmed:24988067Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The 2014International Workshop on Alport Syndrome.</title><author><name sortKey="Miner, Jeffrey H" sort="Miner, Jeffrey H" uniqKey="Miner J" first="Jeffrey H" last="Miner">Jeffrey H. Miner</name><affiliation><nlm:affiliation>Renal Division, Washington University School of Medicine, St Louis, Missouri, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Baigent, Colin" sort="Baigent, Colin" uniqKey="Baigent C" first="Colin" last="Baigent">Colin Baigent</name><affiliation><nlm:affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Flinter, Frances" sort="Flinter, Frances" uniqKey="Flinter F" first="Frances" last="Flinter">Frances Flinter</name><affiliation><nlm:affiliation>Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Gross, Oliver" sort="Gross, Oliver" uniqKey="Gross O" first="Oliver" last="Gross">Oliver Gross</name><affiliation><nlm:affiliation>Clinic of Nephrology and Rheumatology, University Medicine Goettingen, Goettingen, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Judge, Parminder" sort="Judge, Parminder" uniqKey="Judge P" first="Parminder" last="Judge">Parminder Judge</name><affiliation><nlm:affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Kashtan, Clifford E" sort="Kashtan, Clifford E" uniqKey="Kashtan C" first="Clifford E" last="Kashtan">Clifford E. Kashtan</name><affiliation><nlm:affiliation>Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lagas, Sharon" sort="Lagas, Sharon" uniqKey="Lagas S" first="Sharon" last="Lagas">Sharon Lagas</name><affiliation><nlm:affiliation>Alport Syndrome Foundation, Phoenix, Arizona, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Savige, Judith" sort="Savige, Judith" uniqKey="Savige J" first="Judith" last="Savige">Judith Savige</name><affiliation><nlm:affiliation>Melbourne Health, The University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Blatt, Dave" sort="Blatt, Dave" uniqKey="Blatt D" first="Dave" last="Blatt">Dave Blatt</name><affiliation><nlm:affiliation>Alport Foundation of Australia, Valentine, New South Wales, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Ding, Jie" sort="Ding, Jie" uniqKey="Ding J" first="Jie" last="Ding">Jie Ding</name><affiliation><nlm:affiliation>Pediatric Department, Peking University First Hospital, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Gale, Daniel P" sort="Gale, Daniel P" uniqKey="Gale D" first="Daniel P" last="Gale">Daniel P. Gale</name><affiliation><nlm:affiliation>University College London-Center for Nephrology, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Midgley, Julian P" sort="Midgley, Julian P" uniqKey="Midgley J" first="Julian P" last="Midgley">Julian P. Midgley</name><affiliation><nlm:affiliation>Department of Pediatrics, Alberta Children's Hospital, Calgary, Alberta, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Povey, Sue" sort="Povey, Sue" uniqKey="Povey S" first="Sue" last="Povey">Sue Povey</name><affiliation><nlm:affiliation>Department of Genetics, Evolution and Environment, University College London, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Prunotto, Marco" sort="Prunotto, Marco" uniqKey="Prunotto M" first="Marco" last="Prunotto">Marco Prunotto</name><affiliation><nlm:affiliation>Discovery Technology Department, Pharma Research and Early Development, Basel, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Renault, Daniel" sort="Renault, Daniel" uniqKey="Renault D" first="Daniel" last="Renault">Daniel Renault</name><affiliation><nlm:affiliation>Association for Information and Research on Genetic Renal Diseases (AIRG)-France, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Skelding, Jules" sort="Skelding, Jules" uniqKey="Skelding J" first="Jules" last="Skelding">Jules Skelding</name><affiliation><nlm:affiliation>Alport UK, Tetbury, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Turner, A Neil" sort="Turner, A Neil" uniqKey="Turner A" first="A Neil" last="Turner">A Neil Turner</name><affiliation><nlm:affiliation>Renal Medicine, Royal Infirmary, University of Edinburgh, Edinburgh, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Gear, Susie" sort="Gear, Susie" uniqKey="Gear S" first="Susie" last="Gear">Susie Gear</name><affiliation><nlm:affiliation>Alport UK, Tetbury, UK.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24988067</idno><idno type="pmid">24988067</idno><idno type="doi">10.1038/ki.2014.229</idno><idno type="wicri:Area/PubMed/Corpus">003403</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003403</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The 2014International Workshop on Alport Syndrome.</title><author><name sortKey="Miner, Jeffrey H" sort="Miner, Jeffrey H" uniqKey="Miner J" first="Jeffrey H" last="Miner">Jeffrey H. Miner</name><affiliation><nlm:affiliation>Renal Division, Washington University School of Medicine, St Louis, Missouri, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Baigent, Colin" sort="Baigent, Colin" uniqKey="Baigent C" first="Colin" last="Baigent">Colin Baigent</name><affiliation><nlm:affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Flinter, Frances" sort="Flinter, Frances" uniqKey="Flinter F" first="Frances" last="Flinter">Frances Flinter</name><affiliation><nlm:affiliation>Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Gross, Oliver" sort="Gross, Oliver" uniqKey="Gross O" first="Oliver" last="Gross">Oliver Gross</name><affiliation><nlm:affiliation>Clinic of Nephrology and Rheumatology, University Medicine Goettingen, Goettingen, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Judge, Parminder" sort="Judge, Parminder" uniqKey="Judge P" first="Parminder" last="Judge">Parminder Judge</name><affiliation><nlm:affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Kashtan, Clifford E" sort="Kashtan, Clifford E" uniqKey="Kashtan C" first="Clifford E" last="Kashtan">Clifford E. Kashtan</name><affiliation><nlm:affiliation>Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lagas, Sharon" sort="Lagas, Sharon" uniqKey="Lagas S" first="Sharon" last="Lagas">Sharon Lagas</name><affiliation><nlm:affiliation>Alport Syndrome Foundation, Phoenix, Arizona, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Savige, Judith" sort="Savige, Judith" uniqKey="Savige J" first="Judith" last="Savige">Judith Savige</name><affiliation><nlm:affiliation>Melbourne Health, The University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Blatt, Dave" sort="Blatt, Dave" uniqKey="Blatt D" first="Dave" last="Blatt">Dave Blatt</name><affiliation><nlm:affiliation>Alport Foundation of Australia, Valentine, New South Wales, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Ding, Jie" sort="Ding, Jie" uniqKey="Ding J" first="Jie" last="Ding">Jie Ding</name><affiliation><nlm:affiliation>Pediatric Department, Peking University First Hospital, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Gale, Daniel P" sort="Gale, Daniel P" uniqKey="Gale D" first="Daniel P" last="Gale">Daniel P. Gale</name><affiliation><nlm:affiliation>University College London-Center for Nephrology, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Midgley, Julian P" sort="Midgley, Julian P" uniqKey="Midgley J" first="Julian P" last="Midgley">Julian P. Midgley</name><affiliation><nlm:affiliation>Department of Pediatrics, Alberta Children's Hospital, Calgary, Alberta, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Povey, Sue" sort="Povey, Sue" uniqKey="Povey S" first="Sue" last="Povey">Sue Povey</name><affiliation><nlm:affiliation>Department of Genetics, Evolution and Environment, University College London, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Prunotto, Marco" sort="Prunotto, Marco" uniqKey="Prunotto M" first="Marco" last="Prunotto">Marco Prunotto</name><affiliation><nlm:affiliation>Discovery Technology Department, Pharma Research and Early Development, Basel, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Renault, Daniel" sort="Renault, Daniel" uniqKey="Renault D" first="Daniel" last="Renault">Daniel Renault</name><affiliation><nlm:affiliation>Association for Information and Research on Genetic Renal Diseases (AIRG)-France, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Skelding, Jules" sort="Skelding, Jules" uniqKey="Skelding J" first="Jules" last="Skelding">Jules Skelding</name><affiliation><nlm:affiliation>Alport UK, Tetbury, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Turner, A Neil" sort="Turner, A Neil" uniqKey="Turner A" first="A Neil" last="Turner">A Neil Turner</name><affiliation><nlm:affiliation>Renal Medicine, Royal Infirmary, University of Edinburgh, Edinburgh, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Gear, Susie" sort="Gear, Susie" uniqKey="Gear S" first="Susie" last="Gear">Susie Gear</name><affiliation><nlm:affiliation>Alport UK, Tetbury, UK.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Kidney international</title><idno type="eISSN">1523-1755</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Autoantigens (genetics)</term><term>Autoantigens (metabolism)</term><term>Clinical Trials as Topic</term><term>Collagen Type IV (genetics)</term><term>Collagen Type IV (metabolism)</term><term>Genetic Testing</term><term>Glomerular Basement Membrane (metabolism)</term><term>Humans</term><term>Nephritis, Hereditary (diagnosis)</term><term>Nephritis, Hereditary (drug therapy)</term><term>Nephritis, Hereditary (genetics)</term><term>Patient Selection</term><term>Podocytes</term><term>Registries</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Autoantigens</term><term>Collagen Type IV</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Autoantigens</term><term>Collagen Type IV</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Nephritis, Hereditary</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Nephritis, Hereditary</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Nephritis, Hereditary</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Glomerular Basement Membrane</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Clinical Trials as Topic</term><term>Genetic Testing</term><term>Humans</term><term>Patient Selection</term><term>Podocytes</term><term>Registries</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Alport syndrome, historically referred to as hereditary glomerulonephritis with sensorineural deafness and anterior lenticonus, is a genetic disease of collagen α3α4α5(IV) resulting in renal failure. The collagen α3α4α5(IV) heterotrimer forms a network that is a major component of the kidney glomerular basement membrane (GBM) and basement membranes in the cochlea and eye. Alport syndrome, estimated to affect 1 in 5000-10,000 individuals, is caused by mutations in any one of the three genes that encode the α chain components of the collagen α3α4α5(IV) heterotrimer: COL4A3, COL4A4, and COL4A5. Although angiotensin-converting enzyme inhibition is effective in Alport syndrome patients for slowing progression to end-stage renal disease, it is neither a cure nor an adequate long-term protector. The 2014 International Workshop on Alport Syndrome, held in Oxford, UK, from January 3-5, was organized by individuals and families living with Alport syndrome, in concert with international experts in the clinical, genetic, and basic science aspects of the disease. Stakeholders from diverse communities-patient families, physicians, geneticists, researchers, Pharma, and funding organizations-were brought together so that they could meet and learn from each other and establish strategies and collaborations for the future, with the overall aim of discovering much needed new treatments to prolong kidney function.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24988067</PMID><DateCreated><Year>2014</Year><Month>09</Month><Day>30</Day></DateCreated><DateCompleted><Year>2015</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-1755</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Kidney international</Title><ISOAbbreviation>Kidney Int.</ISOAbbreviation></Journal><ArticleTitle>The 2014International Workshop on Alport Syndrome.</ArticleTitle><Pagination><MedlinePgn>679-84</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/ki.2014.229</ELocationID><Abstract><AbstractText>Alport syndrome, historically referred to as hereditary glomerulonephritis with sensorineural deafness and anterior lenticonus, is a genetic disease of collagen α3α4α5(IV) resulting in renal failure. The collagen α3α4α5(IV) heterotrimer forms a network that is a major component of the kidney glomerular basement membrane (GBM) and basement membranes in the cochlea and eye. Alport syndrome, estimated to affect 1 in 5000-10,000 individuals, is caused by mutations in any one of the three genes that encode the α chain components of the collagen α3α4α5(IV) heterotrimer: COL4A3, COL4A4, and COL4A5. Although angiotensin-converting enzyme inhibition is effective in Alport syndrome patients for slowing progression to end-stage renal disease, it is neither a cure nor an adequate long-term protector. The 2014 International Workshop on Alport Syndrome, held in Oxford, UK, from January 3-5, was organized by individuals and families living with Alport syndrome, in concert with international experts in the clinical, genetic, and basic science aspects of the disease. Stakeholders from diverse communities-patient families, physicians, geneticists, researchers, Pharma, and funding organizations-were brought together so that they could meet and learn from each other and establish strategies and collaborations for the future, with the overall aim of discovering much needed new treatments to prolong kidney function.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miner</LastName><ForeName>Jeffrey H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Renal Division, Washington University School of Medicine, St Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baigent</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flinter</LastName><ForeName>Frances</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gross</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Clinic of Nephrology and Rheumatology, University Medicine Goettingen, Goettingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Judge</LastName><ForeName>Parminder</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashtan</LastName><ForeName>Clifford E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagas</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Alport Syndrome Foundation, Phoenix, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savige</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Melbourne Health, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blatt</LastName><ForeName>Dave</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Alport Foundation of Australia, Valentine, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pediatric Department, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gale</LastName><ForeName>Daniel P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>University College London-Center for Nephrology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Midgley</LastName><ForeName>Julian P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Alberta Children's Hospital, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Povey</LastName><ForeName>Sue</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Genetics, Evolution and Environment, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prunotto</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Discovery Technology Department, Pharma Research and Early Development, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renault</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Association for Information and Research on Genetic Renal Diseases (AIRG)-France, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skelding</LastName><ForeName>Jules</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Alport UK, Tetbury, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>A Neil</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Renal Medicine, Royal Infirmary, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gear</LastName><ForeName>Susie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Alport UK, Tetbury, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>086034</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G1002528</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 DK078314</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 DK095419</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016423">Congresses</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Kidney Int</MedlineTA><NlmUniqueID>0323470</NlmUniqueID><ISSNLinking>0085-2538</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C466620">COL4A4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C478159">COL4A5 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024141">Collagen Type IV</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C057112">type IV collagen alpha3 chain</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Pediatr Nephrol. 2009 Oct;24(10):1951-8</RefSource><PMID Version="1">17912554</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene Ther. 1996 Jan;3(1):21-7</RefSource><PMID Version="1">8929908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2002 Feb;160(2):721-30</RefSource><PMID Version="1">11839593</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Matrix Biol. 2010 Jun;29(5):346-56</RefSource><PMID Version="1">20307660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatr Nephrol. 2013 Jan;28(1):5-11</RefSource><PMID Version="1">22461141</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2014 Apr;25(4):687-92</RefSource><PMID Version="1">24262794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Hum Genet. 2012 Jun;20(6). doi: 10.1038/ejhg.2011.237</RefSource><PMID Version="1">22166944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Matrix Biol. 2014 Feb;34:13-21</RefSource><PMID Version="1">24480069</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv124-30</RefSource><PMID Version="1">25165179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatr Nephrol. 2014 Jun;29(6):971-7</RefSource><PMID Version="1">23720012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2014 Feb;25(2):260-75</RefSource><PMID Version="1">24262798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2003 Jun 19;348(25):2543-56</RefSource><PMID Version="1">12815141</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2013 Oct;183(4):1269-80</RefSource><PMID Version="1">23911822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatr Nephrol. 2013 Jul;28(7):1025-36</RefSource><PMID Version="1">22903660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2000 Apr;11(4):649-57</RefSource><PMID Version="1">10752524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Kidney Int. 2009 Nov;76(9):968-76</RefSource><PMID Version="1">19710627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2014 May;25(5):939-51</RefSource><PMID Version="1">24436468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Kidney Int. 1992 Jul;42(1):115-26</RefSource><PMID Version="1">1635341</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nephrol Dial Transplant. 2009 Mar;24(3):731-4</RefSource><PMID Version="1">19110486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2012 Apr;23(4):661-73</RefSource><PMID Version="1">22302195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nephrol Dial Transplant. 2009 Sep;24(9):2721-9</RefSource><PMID Version="1">19357112</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Kidney Int. 2007 Apr;71(7):615-8</RefSource><PMID Version="1">17290292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2013 Feb;24(3):364-75</RefSource><PMID Version="1">23349312</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):331-6</RefSource><PMID Version="1">24344311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2003 Oct;14(10):2603-10</RefSource><PMID Version="1">14514738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2004 Oct;15(10):2514-27</RefSource><PMID Version="1">15466256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Kidney Int. 2014 Jun;85(6):1461-8</RefSource><PMID Version="1">24522496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Sep 4;325(5945):1230-4</RefSource><PMID Version="1">19729652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2012 Sep;8(9):784-90</RefSource><PMID Version="1">22842973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ISRN Pediatr. 2012;2012:436046</RefSource><PMID Version="1">22811928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2013 Dec;24(12):1945-54</RefSource><PMID Version="1">24052634</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001324" MajorTopicYN="N">Autoantigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024141" MajorTopicYN="N">Collagen Type IV</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050533" MajorTopicYN="N">Glomerular Basement Membrane</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009394" MajorTopicYN="N">Nephritis, Hereditary</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050199" MajorTopicYN="N">Podocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">NIHMS605857</OtherID><OtherID Source="NLM">PMC4182137</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>02</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>03</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>04</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24988067</ArticleId><ArticleId IdType="pii">S0085-2538(15)30392-6</ArticleId><ArticleId IdType="doi">10.1038/ki.2014.229</ArticleId><ArticleId IdType="pmc">PMC4182137</ArticleId><ArticleId IdType="mid">NIHMS605857</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003403 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003403 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:24988067
|texte= The 2014International Workshop on Alport Syndrome.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24988067" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |